Diagnostics involves investigating and discovering certain diseases, conditions and injuries by closely studying various symptoms and indications displayed by patients. In broad terms, today’s Diagnostics Industry breaks down into the following categories, namely in-vitro diagnostics (IVD) (examination of diverse tissue samples in a laboratory) and in-vivo diagnostics (observation and testing of tissue and any organ’s functioning by exploiting the techniques like medical (diagnostic) imaging and monitoring).
A nearly EUR 37.5 billion sector, in-vitro diagnostics promises enormous growth potential, with governments increasingly redefining soaring healthcare spending and starting to pour investments into the high tech diagnostics business. The latter continues to be superintended by a mere scattering of behemoths. Major forces fuelling the industry development include, among others, innovative approaches regarding equipment and clinical trial activities.
This Catalogue presents an invaluable collection of research reports examining the Diagnostics and Diseases Market worldwide, by various regions and selected countries. The research reports feature market sizing analyses and growth rate reviews, discussions of factors diving or deterring the growth of the Diagnostics and Diseases Industry, information on market dynamics and share, etc. The profiles of large-to-micro caps, and the Diagnostics and Diseases Market forecasts are provided in the research reports too.
Publications found:
43,323
Sort by:
2024 US Endocrine Function Testing Market for 20 Assays: Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Competitive Landscape, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 2,850.00
This new 271-page report from LeadingMarketResearch.com provides a comprehensive analysis in the US endocrine function market, including emerging tests, technologies, instrumentation, sales forecasts...
August 2020
271 pages
2024 US Therapeutic Drug Monitoring (TDM) Market for 28 Assays: Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Competitive Landscape, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 2,450.00
This new 249-page report from LeadingMarketResearch.com provides a comprehensive analysis of the US therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales f...
August 2020
249 pages
Global Liver Cancer Therapeutics Market, By Cancer Type (Hepatocellular Carcinoma, Cholangiocarcinoma, Liver Metastasis, Hepatoblastoma, Angiosarcoma), By Therapy (Targeted Therapy, Radiation and Chemotherapy Therapy, Immunotherapy, Others), By Equipment (Computed Radiography, MRI, Sonography, Others), By Age (0-18, 18-35, 35-50, 50+), By Factors (Non-Alcoholic Fatty Liver Disease, Cirrhosis, Excessive Liver Consumption, Others), By Route of Administration (Oral, Intra-Venous, Others ), By Distribution channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region, Competition, Forecast & Opportunities, 2025
US$ 4,900.00
Global liver cancer therapeutics market is forecast to grow in the coming years and reach $ 11 billion by 2025. Major factors behind the growth of this market include rising cases of liver cancer, glo...
August 2020
129 pages
